Memoria de actividades InMusc 2014


  • Primer PREMIO SER 2014 al mejor trabajo en Epidemiología en Enfermedades Reumáticas en el año 2013, por la publicación: “Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases
  • PREMIO SER 2014 DE ESPONDILOARTRITIS al mejor trabajo presentado sobre cualquier aspecto de Espondiloartritis en el año 2013, por la publicación: “Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza Programme


  • Eular Taskfor on Transition from Rheumatic Pediatric Clinics to Adult Rheumatology
  • Eular Taskfor on the management of Familial Mediterranean Fever
  • Programa de ejercicio en espondioartritis (EJES-3D). Hospital Fundación Alcorcón – GRESSER.
  • Development of a definition for Early Osteoarthritis. Italian Society of Rheumatology
  • Registro de AIJ-sistémica y enfermedad de Still del adulto. Proyecto de la Sociedad de Reumatología Pediátrica (SERPE).
  • Proyecto GECOAR: Gestión de la Comorbilidad en artritis reumatoide. Sociedad Madrileña de Reumatología (SORCOM).
  • Recomendaciones para la detección, investigación y derivación del dolor lumbar inflamatorio en atención primaria. Grupo de Dolor Lumbar Inflamatorio, financiado por MSD.
  • The BRAF and RAID study – Cross-cultural validation of two Rheumatoid Arthritis Patient-Reported Outcome Measures (PROMs): Bristol RA Fatigue and RA Impact of Disease scales. IP: Sarah Hewlett, Bristol, UK. Financia: Eular


  1. Abad MA, Ariza RA, Aznar JJ, Batlle E, Beltran E, de Dios Canete J, et al. Standards of care for patients with spondyloarthritis. Rheumatol Int. 2014;34(2):165-70.
  2. Busquets N, Vaquero CG, Moreno JR, Vilaseca DR, Narváez J, Carmona L, Nolla JM. Bone mineral density status and frequency of osteoporosis and clinical fractures in 155 patients with psoriatic arthritis followed in a university hospital. Reumatol Clin, 2014; 10(2): 89-93.
  3. Carmona L, de la Vega M, Ranza R, Casado G, Titton DC, Descalzo MA, Gómez-Reino JJ. BIOBADASER, BIOBADAMERICA, and BIOBADADERM: safety registers sharing commonalities across diseases and countries. Clin Exp Rheumatol, 2014 Nov-Dec;32 Suppl 85(5):163-167
  4. Castrejon I, Toledano E, Rosario MP, Loza E, Perez-Ruiz F, Carmona L. Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis. Rheumatol Int. 2014.
  5. Cobo-Ibanez T, Descalzo MA, Loza-Santamaria E, Carmona L, Munoz-Fernandez S. Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0. Rheumatol Int. 2014;34(7):953-61.
  6. Cobo-Ibanez T, Loza-Santamaria E, Pego-Reigosa JM, Marques AO, Rua-Figueroa I, Fernandez-Nebro A, et al. Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: A systematic review. Semin Arthritis Rheum. 2014;44(2):175-85.
  7. Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R, Woolf A, March L. The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis, 2014; 73(7): 1316–1322.
  8. Curbelo RJ, Loza E, de Yébenes MJ, Carmona L. Databases and registers: useful tools for research, no studies. Rheumatol Int, 2014; 34: 447-452
  9. Diaz-Heredia J, Loza E, Cebreiro I, Ruiz Iban MA. Preventive analgesia in hip or knee arthroplasty: a systematic review. Rev Esp Cir Ortop Traumatol. 2014.
  10. Fernández-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA, Collantes-Estévez E, Mulero J, Muñoz-Fernández S, Zarco P, Carmona L; ESPERANZA Study Group. Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Ann Rheum Dis, 2014; 73(7):1350-1355
  11. García-Vicuña R, Montoro M, Egües Dubuc CA, Bustabad Reyes S, Gómez-Centeno A, Muñoz-Fernández S, Pérez Pampín E, Román Ivorra JA, Balsa A, Loza E. Quality standards in a rheumatology Day-Care Hospital Unit. The proposal of the Spanish Society of Rheumatology Day Hospitals’ Working Group. Reumatol Clin. 2014;10(6):380-8.
  12. Garrido-Castro JL, Escudero A, Medina-Carnicer R, Galisteo AM, Gonzalez-Navas C, Carmona L, Collantes-Estevez E. Validation of a new objective index to measure spinal mobility: the University of Cordoba Ankylosing Spondylitis Metrology Index (UCOASMI). Rheumatol Int, 2014 Mar;34(3):401-6
  13. Haro J, Tyrovolas S, Garin N, Diaz-Torne C, Carmona L, Riera L, Perez-Ruiz F, Murray C. The burden of disease in Spain: results from the global burden of disease study 2010. BMC Med, 2014 Dec 5;12(1):236
  14. Kearsley-Fleet L, Závada J, Hetland ML, Nordström DC, Aaltonen KJ, Listing J, Zink A, Gati T, Rojkovich B, Iannone F, Gremese E, van Riel PL, van de Laar MA, Lie E, Kvien TK, Canhão H, Fonseca JE, Rotar Z, Loza E, Carmona L, Askling J, Johansson K, Finckh A, Dixon WG, Hyrich KL; on behalf of the EULAR Study Group for Registers and Observational Drug Studies. The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers. Rheumatology (Oxford). 2014.
  15. L Carmona. Is there a best way to measure co-morbidity? Rheumatology, 2014 Jun;53(6):963-4
  16. Moe RH, Petersson IF, Carmona L, Greiff R, Guillemin F, Udrea G, Loza E, Stoffer MA, de Wit M, Wiek D, Vliet Vlieland T, Woolf AD, Uhlig T; the EUMUSC.NET working group. Facilitators to implement standards of care for rheumatoid arthritis and osteoarthritis: the EUMUSC.NET project. Ann Rheum Dis, 2014 Aug;73(8):1545-8.
  17. Perez-Ruiz F, Martínez-Indart L, Carmona L, Herrero-Beites AM, Pijoan JI, Krishnan E. Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis, 2014 Jan 1;73(1):177-82.
  18. Petersson IF, Strombeck B, Andersen L, Cimmino M, Greiff R, Loza E, et al. Development of healthcare quality indicators for rheumatoid arthritis in Europe: the project. Ann Rheum Dis. 2014;73(5):906-8.
  19. Rua-Figueroa I, Lopez-Longo FJ, Calvo-Alen J, Galindo-Izquierdo M, Loza E, Garcia de Yebenes MJ, et al. National registry of patients with systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and methodology. Reumatol Clin. 2014;10(1):17-24.
  20. Ruiz Iban MA, Macule F, Torner P, Gil Garay E, Oteo A, Lopez Millan JM, et al. SECOT-GEDOS consensus on pre-surgical pain management in knee and hip arthrosis. Rev Esp Cir Ortop Traumatol. 2014.
  21. Salgado E, Maneiro JR, Carmona L, Gómez-Reino J. Rheumatoid factor and response to TNF antagonists in rheumatoid arthritis: Systematic review and meta-analysis of observational studies. Joint Bone Spine, 2014 Jan;81(1):41-50
  22. Salgado E, Maneiro JR, Carmona L, Gomez-Reino JJ. Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis. Ann Rheum Dis, 2014; 73(5):871-82.
  23. Silva-Fernandez L, Loza E, Martinez-Taboada VM, Blanco R, Rua-Figueroa I, Pego-Reigosa JM, et al. Biological therapy for systemic vasculitis: a systematic review. Semin Arthritis Rheum. 2014;43(4):542-57.
  24. Sivera F, Andrés M, Carmona L, Kydd AS, Moi J, Seth R, Sriranganathan M, van Durme C, van Echteld I, Vinik O, Wechalekar MD, Aletaha D, Bombardier C, Buchbinder R, Edwards CJ, Landewé RB, Bijlsma JW, Branco JC, Burgos-Vargas R, Catrina AI, Elewaut D, Ferrari AJ, Kiely P, Leeb BF, Montecucco C, Müller-Ladner U, Ostergaard M, Zochling J, Falzon L, van der Heijde DM. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 2014, Feb 1;73(2):328-35
  25. Souto A, Maneiro JR, Salgado E, Carmona L, Gomez-Reino JJ. Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies. Rheumatology (Oxford). 2014 Oct; 53(10): 1872-85.
  26. Stoffer MA, Smolen JS, Woolf A, Ambrozic A, Berghea F, Boonen A, et al. Development of patient-centred standards of care for osteoarthritis in Europe: the Ann Rheum Dis. 2014.
  27. Stoffer MA, Smolen JS, Woolf A, Ambrozic A, Bosworth A, Carmona L, Fialka-Moser V, Loza E, Olejnik P, Petersson IF, Uhlig T, Stamm TA; the group. Development of patient-centred standards of care for rheumatoid arthritis in Europe: the project. Ann Rheum Dis, 2014;73(5):902-5
  28. Tomero E, Mulero J, de Miguel E, Fernández-Espartero C, Gobbo M, Descalzo MA, Collantes-Estévez E, Zarco P, Muñoz-Fernández S, Carmona L; the ESPERANZA Study Group. Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme. Rheumatology, 2014 53: 353-360.
  29. Villaverde V, Rosario MP, Loza E, Perez F. Systematic review of the value of ultrasound and magnetic resonance musculoskeletal imaging in the evaluation of response to treatment of gout. Reumatol Clin. 2014;10(3):160-3.
  30. Yebenes MG, Loza E, Carmona L. Predicting Toxicity: Biomarkers and the Value of the Patient’s Opinion. Curr Pharm Des. 2014;21(2):233-40.